You are here:Home-Chemical Inhibitors & Agonists-Metabolic Enzyme/Protease-Protein Phosphatase/PTP-PTPN2 inhibitor 9
PTPN2 inhibitor 9

Chemical Structure : PTPN2 inhibitor 9

CAS No.: 2640368-36-9

PTPN2 inhibitor 9 (PTP 9)

Catalog No.: PC-20339Not For Human Use, Lab Use Only.

PTPN2 inhibitor 9 (PTP9) is small molecule inhibitor of protein tyrosine phosphatase non-receptor type 2 (PTPN2), sensitizes tumor cells to IFNγ treatment in vitro and to anti-PD-1 therapy in vivo.

Packing Price Stock Quantity
50 mg Get quote
100 mg Get quote
250 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

    Biological Activity

    PTPN2 inhibitor 9 (PTP9) is small molecule inhibitor of protein tyrosine phosphatase non-receptor type 2 (PTPN2), sensitizes tumor cells to IFNγ treatment in vitro and to anti-PD-1 therapy in vivo.
    PTP9 significantly upregulated both Cxcl11 and Ccl5 under the IFNγ stimulation condition in IFNγ and TNFα-treated B16F10 cells. PTP9 PTP9 mimicked Ptpn2 knockout phenotype in sensitizing B16F10 cells to IFNγ treatment in vitro.
    PTP9 suppressed B16F10 cell growth and enhanced Stat1 phosphorylation and expression of IFNγ response genes.
    PTP9 effectively sensitized B16F10 melanoma to ICI therapy in vivo, by restoring the ability to respond to IFNγ, thereby increasing T-cell chemokine expression and recruitment of cytolytic T cells to the tumor microenvironment.
    PTP9 sensitized cancer cells to the effects of IFNγ and TNFα are not restricted to melanoma cells but extend to other solid tumors, many of which exhibit resistance to ICI therapy.

    Physicochemical Properties

    M.Wt 416.43
    Formula C24H20N2O5
    Appearance Solid
    CAS No.
    Storage
    Solide Powder
    -20°C 12 Months; 4°C 6 Months
    In Solvent
    -80°C 6 Months; -20°C 6 Months
    Shipping
    Solubility

    10 mM in DMSO

    Chemical Name/SMILES

    methyl 4-((5-(furan-2-yl)-3-(4-(methoxycarbonyl)phenyl)-1H-pyrazol-4-yl)methyl)benzoate

    References

    1. Zhu Z, et al. Cancer Res Commun. 2023 Jan 24;3(1):119-129.

    Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

    Contact Us sales@probechem.com

    Bulk Inquiry

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • *Additional Information:

    Get Quote

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • Additional Information: